APA (7th ed.) Citation

Li, L., Wu, H., Chen, Y., Yuan, H., Wu, J., Wu, X., . . . Zhang, J. (2020). Population Pharmacokinetics Study of Contezolid (MRX-I), a Novel Oxazolidinone Antibacterial Agent, in Chinese Patients. Clinical therapeutics, 42(5), 818-829. https://doi.org/10.1016/j.clinthera.2020.03.020

Chicago Style (17th ed.) Citation

Li, Li, et al. "Population Pharmacokinetics Study of Contezolid (MRX-I), a Novel Oxazolidinone Antibacterial Agent, in Chinese Patients." Clinical Therapeutics 42, no. 5 (2020): 818-829. https://doi.org/10.1016/j.clinthera.2020.03.020.

MLA (9th ed.) Citation

Li, Li, et al. "Population Pharmacokinetics Study of Contezolid (MRX-I), a Novel Oxazolidinone Antibacterial Agent, in Chinese Patients." Clinical Therapeutics, vol. 42, no. 5, 2020, pp. 818-829, https://doi.org/10.1016/j.clinthera.2020.03.020.